Evidence map›Paper›PMID 41981940›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2026

Proteomic Trajectories of Metabolic and Proteostatic Adaptation During Normothermic Liver Perfusion.

Heithem Jeddou, Anne-Aurélie Raymond, Jean-William Dupuy, Cyril Dourthe, Hector Prudhomme, Eya Ben Nejma, Stylianos Tzedakis, Bruno Turlin, Pierre Allaume, Karim Boudjema and 1 more

Abstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Proteomic Trajectories of Metabolic and Proteostatic Adaptation During Normothermic Liver Perfusion.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Heithem JeddouService de Chirurgie Hépatobiliaire et Digestive, CHU Rennes, Rennes, France.ORCID 0000-0002-3722-904X
Anne-Aurélie RaymondUniversité de Bordeaux, CNRS, INSERM, TBM-Core, US5, UAR 3427, Bordeaux, France.
Jean-William DupuyUniversité de Bordeaux, CNRS, INSERM, TBM-Core, US5, UAR 3427, Bordeaux, France.ORCID 0000-0002-2448-4797
Cyril DourtheUniversité de Bordeaux, CNRS, INSERM, TBM-Core, US5, UAR 3427, Bordeaux, France.
Hector PrudhommeService de Chirurgie Hépatobiliaire et Digestive, CHU Rennes, Rennes, France.
Eya Ben NejmaService de Chirurgie Hépatobiliaire et Digestive, CHU Rennes, Rennes, France.
Stylianos TzedakisService de Chirurgie Digestive, Hépatobiliaire et Endocrinienne, Hôpital Cochin, AP-HP, Université Paris Cité, Paris, France.
Bruno TurlinService D'anatomie Pathologique, CHU Rennes, Rennes, France.
Pierre AllaumeService D'anatomie Pathologique, CHU Rennes, Rennes, France.ORCID 0000-0002-6179-3396
Karim BoudjemaService de Chirurgie Hépatobiliaire et Digestive, CHU Rennes, Rennes, France.
Michel SamsonInserm, EHESP, Université de Rennes, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.

Funding

Université de Rennes 1
6 · The paper itself

Abstract

backgroundNormothermic machine perfusion (NMP) enables metabolic restoration and viability testing of liver grafts, but current viability criteria incompletely predict post-transplant outcomes. The molecular basis of graft resilience or biliary vulnerability remains unclear. This study aimed to characterise tissue-level proteomic trajectories during NMP and early reperfusion to identify molecular signatures associated with biliary complications after liver transplantation (LT).

methodsThis prospective, single-centre study was conducted at Rennes University Hospital. Twenty donation-after-brain-death (DBD) livers underwent NMP; sixteen transplanted grafts with complete sequential biopsies and ≥ 6 months of follow-up were analysed. Biopsies were collected after cold storage (B1), at the end of NMP (B2), and 1 h after graft reperfusion (B3). Proteins were quantified by high-resolution LC-MS/MS and analysed with Proteome Discoverer 3.1/Chimerys. Pathway enrichment used Ingenuity Pathway Analysis to compare grafts with and without biliary complications.

resultsPrincipal component analysis revealed distinct proteomic profiles between grafts with and without complications at all biopsy time points. During NMP (B2/B1), uncomplicated grafts showed glycolytic activation with attenuation of oxidative phosphorylation, whereas complicated grafts showed blunted glycolysis and mild OXPHOS upregulation. At reperfusion (B3/B2), complicated grafts displayed induction of translational and endoplasmic-reticulum-stress pathways, while resilient grafts maintained proteasome-related protein turnover and enrichment of a hypoxia-response signature driven by ELOC and proteasome subunits.

conclusionsSequential tissue proteomics during NMP reveals divergent metabolic and proteostatic adaptations linked to biliary outcomes. Glycolytic activation with preserved protein turnover characterises resilient grafts, whereas translational and ER-stress programmes predominate in complicated ones. These insights may refine viability assessment beyond biochemical criteria.

Indexed as

LiverLiver TransplantationOrgan PreservationPerfusionProteomeProteostasisAdaptation, PhysiologicalFemaleGlycolysisHumansMaleOxidative PhosphorylationProspective StudiesProteomicsTandem Mass SpectrometryProteomebiliary complicationsgraft viabilityischemia–reperfusion injuryliver transplantationnormothermic machine perfusionproteomics

Identifiers

PMID41981940
PMCPMC13080225

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.